The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-{[5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4-yl]amino}benzoic acid ID: ALA3793474
PubChem CID: 1191479
Max Phase: Preclinical
Molecular Formula: C19H12ClN3O2S
Molecular Weight: 381.84
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(Nc2ncnc3scc(-c4ccc(Cl)cc4)c23)cc1
Standard InChI: InChI=1S/C19H12ClN3O2S/c20-13-5-1-11(2-6-13)15-9-26-18-16(15)17(21-10-22-18)23-14-7-3-12(4-8-14)19(24)25/h1-10H,(H,24,25)(H,21,22,23)
Standard InChI Key: HKTPYABMSOROAE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9971 -3.0138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2935 -3.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2901 -5.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5873 -6.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8881 -5.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8917 -3.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5944 -3.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6221 -3.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9838 -4.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9039 -5.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4624 -5.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1007 -3.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1876 -6.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1869 -7.2270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.2274 -5.4280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1933 -6.7019 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 11 1 0
10 7 1 0
7 5 1 0
4 8 1 0
8 9 1 0
10 11 2 0
9 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 9 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
11 17 1 0
23 24 1 0
23 25 2 0
14 23 1 0
20 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.84Molecular Weight (Monoisotopic): 381.0339AlogP: 5.45#Rotatable Bonds: 4Polar Surface Area: 75.11Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.63CX Basic pKa: 3.10CX LogP: 5.09CX LogD: 2.52Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.58
References 1. Ostrynska OV, Balanda AO, Bdzhola VG, Golub AG, Kotey IM, Kukharenko OP, Gryshchenko AA, Briukhovetska NV, Yarmoluk SM.. (2016) Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines., 115 [PMID:27017545 ] [10.1016/j.ejmech.2016.03.004 ]